Risk of Solid Organ Transplant Rejection Following Vaccination With Pandemrix in the United Kingdom
Phase of Trial: Phase IV
Latest Information Update: 07 Apr 2014
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary) ; Influenza virus vaccine
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 06 Feb 2014 Status changed from active, no longer recruiting to completed as reported by the ClinicalTrial.gov record.
- 05 Jul 2013 Planned End Date changed from 1 Feb 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.
- 08 Feb 2013 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.